Yazdanfar M, Zepeda J, Dean R, Wu J, Levy C, Goldberg D, Lammert C, Prenner S, Reddy KR, Pratt D, Forman L, Assis DN, Lytvyak E, Montano-Loza AJ, Gordon SC, Carey EJ, Ahn J, Schlansky B, Korzenik J, Karagozian R, Hameed B, Chandna S, Yu L, Bowlus CL. African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitis , Hepatol Commun, 8: 2024,e0366
Lauren Shaffer, MD, Daniel Soffer, MD, Stacey Prenner, MD Lipoprotein X Syndrome: A Consideration for Liver Transplant in Primary Sclerosing Cholangitis. Poster Presentation , American College of Gastroenterology, Vancouver Canada: 2023
Peter P Reese, Joshua M Diamond, David S Goldberg, Vishnu Potluri, Stacey Prenner, Emily A Blumberg, Vivianna M Van Deerlin, K Rajender Reddy, Heather Mentch, Richard Hasz, Ashley Woodards, Caren Gentile, Jennifer Smith, Christian Bermudez, Maria M Crespo The SHELTER Trial of Transplanting Hepatitis C Virus-Infected Lungs Into Uninfected Recipients , Transplant Direct, 9(7): 2023
Saine ME, Schnellinger EM., Liu M, Diamond JM, Crespo MM., Prenner S, Potluri V, Bermudez C, Mentch H, Moore M, Besharatian B, Goldberg DS, Barg FK, Reese PP Decision-making Among Hepatitis C Virus-negative Transplant Candidates Offered Organs from Donors with HCV Infection , Transplantation Direct, 8(8): e1341: 2022,e1341
Potluri V, Reese P, Prenner S, Mentch H, Goldberg D, Claridge T, Smith J, Gentile C, Deerlin VVan, Reddy R, Fallah T, Bermudez C, Crespo M, Diamond J. The SHELTER Trial of Transplanting Donor Hepatitis C Virus RNA+ Lungs Into Uninfected Recipients. Oral Presentation. , American Transplant Congress, Philadelphia PA, 22(3): 2022
Ye Tian, Karen Xiao, Chixiang Chen, Kristen Tessiatore, Stacey Prenner and Ethan M Weinberg Degree of Fibrosis in Liver Biopsy Results of NAFLD Patients Significantly Changes Patient's Weight Loss Trajectory. Poster Presentation.
, Hepatology, 74(S1): 2021
Sise ME, Goldberg DS, Kort JJ, Schaubel DE, Alloway RR, Durand CM, Fontana RJ, Brown RS Jr, Friedewald JJ, Prenner S, Landis JR, Fernando M, Phillips CC, Woodle ES, Rike-Shields A, Sherman KE, Elias N, Williams WW, Gustafson JL, Desai NM, Barnaba B, Norman SP, Doshi M, Sultan ST, Aull MJ, Levitsky J, Belshe DS, Chung RT, Reese PP. Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection. Oral Presentation. , J Am Soc Nephrol., 31(11): 2020,2678-2687
Palchaudhuri S, Gabre J, Prenner S, Solga S. COVID-2019.2 Reboot: Returning a GI Fellowship to Pre-pandemic Practices , Dig Dis Sci, 65(9): 2020,2461-2465
Kumar S, Prenner S, Kochman ML. The Impact of COVID-19 on Endoscopic Training , Am J Gastroenterol, 115(7): 2020,1142-1143
N. Mahmud, N. Philips, S. Ekpanyapong, S. Prenner, M. Levine, R. Reddy, M. Hoteit Performance of the Retreat Score in Predicting Post-Transplant Hepatocellular Carcinoma Recurrence at a Large Academic Center. Poster Presentation. , American Transplant Congress, Philadelphia PA: 2020
